Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Syneron Medical Ltd. Announces Availability of its Annual Report on Form 20-F through its Website



Syneron Medical Ltd. Announces Availability of its Annual Report on Form 20-F
                             through its Website

PR Newswire

YOKNEAM ILLIT, Israel, March 21, 2013

YOKNEAM ILLIT, Israel, March 21, 2013 /PRNewswire/ -- Syneron Medical Ltd.
(Nasdaq: ELOS), the leading global aesthetic device company, today announced
that its Annual Report on Form 20-F, containing audited consolidated financial
statements for the year ended December 31, 2012, as filed with the Securities
and Exchange Commission on March 21, 2013, is available on its website
(www.syneron.com). Shareholders may receive a hard copy of the annual report
free of charge upon request. This press release is being issued pursuant to
NASDAQ Listing Rule 5250(d)(1)(C).

(Logo:  http://photos.prnewswire.com/prnh/20120528/535447)

About Syneron Medical Ltd.
Syneron Medical Ltd. (NASDAQ: ELOS) is the leading global aesthetic device
company with a comprehensive product portfolio and a global distribution
footprint. The Company's technology enables physicians to provide advanced
solutions for a broad range of medical-aesthetic applications including body
contouring, hair removal, wrinkle reduction, rejuvenation of the skin's
appearance through the treatment of superficial benign vascular and pigmented
lesions, and the treatment of acne, leg veins and cellulite. The Company sells
its products under two distinct brands, Syneron and Candela. Founded in 2000,
the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd.
are located in Israel. Syneron also has R&D and manufacturing operations in
the US. The Company markets, services and supports its products in 90
countries. It has offices in North America, France, Germany, Italy, Portugal,
Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide.

SOURCE Syneron Medical Ltd.

Website: http://www.syneron.com
Contact: Syneron Contacts: Hugo Goldman, Chief Financial Officer, Syneron
Medical, Email: cfo@syneron.com, +1-866-259-6661
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement